Stem cell watchdog group begins work [Massachusetts]
By Fitchburg Sentinel and Enterprise,
Fitchburg Sentinel and Enterprise
| 09. 22. 2005
BOSTON -- Although there was little action at the first meeting of the state's newly-appointed Biomedical Research Advisory Council, members of the stem cell research watchdog group were already talking about the prospects for the future.
The council was established July 30 by Gov. Mitt Romney and the legislature's leadership, following several months of controversial debate regarding the use of embryonic stem cell research.
"I'm excited about the board's potential," said George Annas, professor of health law at Boston University's College of Public Health.
"It's very important to have a public board to focus on embryonic stem cell research so we can forge ahead."
The 15-member council consists of local biomedical and legal experts and will operate under the Department of Public Health. It will meet at least twice a year.
The bill that called for the establishment of the council also sanctioned embryonic stem cell research and prohibited human cloning, which has board members anticipating great strides in stem cell research.
Annas said the council will monitor stem cell research at biomedical institutions, using the Institute of Medicine's Guidelines...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
